Addiction Disorders
Jonathan Butler, MD, M.Ed.

At the conclusion of this session, the participant will be able to:

• Review the prevalence of addiction disorders in the U.S.
• Discuss the physical, emotional and monetary impact of addiction disorders on the family and socioeconomic structures
• Discuss diagnostic criteria of addiction
• Discuss the etiology and pathophysiology of substance and non-substance addiction, prevention and management

Altered Mental Status in the Presentation of Organic Disease
Mark Traugh, PA-C

At the conclusion of this presentation, the participant will be able to:

• Differentiate between organic and functional psychosis
• Discuss common presentations of new onset mental/emotional status change
• Discuss the differential diagnosis of presenting signs and symptoms
• Discuss the appropriate workup of new onset psychosis

Balance Disorders
Marc Bennett, MD

At the conclusion of this presentation, the participant will be able to:

• Describe the physiology of the balance system
• Discuss signs and symptoms commonly associated with a balance disorder
• Discuss the differential diagnoses of “dizziness”
• Discuss pharmacologic and non-pharmacologic treatment options of vestibular disorders

Childhood Obesity
Janice Pride-Boone, MD

At the conclusion of this presentation, the participant will be able to:

• Discuss the prevalence of childhood obesity in the U.S.
• Discuss common co-morbid disease processes of childhood obesity
• Identify the “at risk” population
• Review causes of childhood obesity, preventive measures and management techniques

Coronary Artery Disease
Dwight Deter, PA-C

This program is brought to you by Partners in Healthcare Education, LLC through an educational grant from Astra Zeneca LLP.

At the conclusion of this presentation, the participant will be able to:

• Discuss the epidemiological impact of CAD in 2008
• List the major risk factors impacting aggressive CAD
• Outline mechanisms designed to identify the earliest presentation of
• Hypertension
• Obesity
• Type 2 diabetes and prediabetes
• Dyslipidemias
• Discuss the inter-relationship between hypertension, obesity, insulin resistance, and dyslipidemias. (Employ case studies to illustrate early, hidden risks in a patient with potential for CAD.)

Cystic Fibrosis Update
Elizabeth Perkett, MD

At the conclusion of this presentation, the participant will be able to:

• Discuss prevalence of cystic fibrosis in the U.S. and identify the at-risk population
• Describe signs and symptoms of cystic fibrosis
• Discuss etiology and pathophysiology of cystic fibrosis
• Review diagnostic work-up of suspected cystic fibrosis
• Discuss treatment options and long-term prognosis of the disease
• Discuss possible future treatment options currently in the research and development pipeline

Developmental /Behavioral Screening for Primary Care Providers: What’s New, What’s Changed and How to Make it Happen
Quentin Humberd, MD, FAAP

At the conclusion of this presentation, the participant will be able to:

• Recognize the difference between developmental/behavioral surveillance and developmental/behavioral screening
• Recognize the importance of early identification and early intervention
• Select and use tools to screen for developmental, emotional, and behavioral problems
• Implement efficient office procedures for screening and referrals
• Develop and use referral procedures for children who exhibit potential concerns

Diabetes Mellitus: New Advances in Optimal Control
Dwight Deter, PA-C 

At the conclusion of this presentation, the participant will be able to:

• Review the pathophysiology of diabetes mellitus
• Discuss latest guidelines and criteria for definitive diagnosis
• Discuss latest recommendations and parameters of acceptable control
• Discuss pharmaceutical and non-pharmaceutical therapies for optimal control

Evaluation of the Red Eye
R. Jason Thurman, MD, FAAEM

At the conclusion of this presentation, the participant will be able to:

• Review the anatomy of the eye and supporting structures
• Identify the signs and symptoms and pathophysiology of the most common etiologies of a red eye
• Identify the "emergent" vs the "non-emergent" red eye
• Discuss standard of care treatment for each "red eye" presentation

Female Genital Disorders and the Family Practitioner
Karen Sexton, PA-C

At the conclusion of this presentation, the participant will be able to:

• Identify normal anatomical landmarks
• Differentiate between benign and worrisome findings
• Discuss the differential diagnoses of vaginal discharge and appropriate workup and treatments
• Discuss newest guidelines for pelvic disease screenings
• Discuss effective pap test collection techniques
• Discuss current treatment guidelines for abnormal pap findings

Prescribing Practices:  Preventing Red Flags
Steve Winbery, MD

At the conclusion of this presentation, the participant will be able to:

• Discuss the prevalence of medication prescribing and its contribution to drug-related morbidity, patient injury and professional liability
• Provide knowledge designed to minimize risk of civil, disciplinary and/or criminal liability that may result from medication prescribing
• Identify specific drug-drug interactions particularly notable in the Medicare population
• Identify potentially inappropriate medications in the Medicare population 

Radiology Review
Martin Jordanov, MD

At the conclusion of this presentation, the participant will be able to:

• Identify normal findings and landmarks on chest, abdomen and joint films
• Identify common technique-related problems
• Discuss commonly found abnormalities on chest, abdomen and joint films
• Review appropriate follow-up on abnormal radiologic testing

The Many Faces of Urticaria
Marvin Cole, PA-C

At the conclusion of this presentation, the participant will be able to:

• Discuss the differential diagnoses of an urticarial rash
• Review signs and symptoms associated with the most common disorders presenting as an urticarial rash
• Discuss appropriate work-up and treatment options for most common urticarial rashes

Vaccination Update
David Hrncir, MD

At the conclusion of this presentation, the participant will be able to:

• Discuss current CDC recommendations for vaccination of children and adults
• Discuss current CDC recommendations for vaccinations in preparation for travel outside the United States
• Discuss possible future vaccinations currently in the research and development pipeline